Literature DB >> 8592072

The self-administered psoriasis area and severity index is valid and reliable.

S R Feldman1, A B Fleischer, D M Reboussin, S R Rapp, M L Exum, A R Clark, L Nurre.   

Abstract

The self-administered psoriasis area and severity index (SAPASI) is a structured instrument for measuring the severity of psoriasis. This study examines the validity, reliability, and responsiveness of the SAPASI. Trained personnel performed a psoriasis area and severity index (PASI) assessment on the same day a SAPASI was obtained from 80 subjects. The validity of the SAPASI was demonstrated using the PASI as the standard (r2 = 0.59, p = 0.0001). Significant correlations were found between SAPASI and PASI for body surface area (r = 0.62-0.75), erythema (r = 0.39), induration (r = 0.24) and scale (r = 0.38). Test-retest reliability was assessed in 19 subjects with repeated evaluations within 2 d. Correlations between the first and second SAPASI scores (r = 0.82) were highly significant (p = 0.0001). Inter-rater reliability of SAPASI body surface area measurements among five raters was very high (intraclass correlation coefficient R = 0.953). The SAPASI was responsive to changes in severity over time as demonstrated by correlation with changes in PASI scores (r = 0.63, p = 0.0002). We conclude that this structured patient self-report instrument facilitates quantitative assessment of psoriasis.

Entities:  

Mesh:

Year:  1996        PMID: 8592072     DOI: 10.1111/1523-1747.ep12329912

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  37 in total

1.  [Psychosocial consequences of psoriasis--an empirical study of disease burden in 3753 affected people].

Authors:  G Schmid-Ott; P Malewski; I Kreiselmaier; U Mrowietz
Journal:  Hautarzt       Date:  2005-05       Impact factor: 0.751

Review 2.  Systematic review of cost-effectiveness analyses of treatments for psoriasis.

Authors:  Wei Zhang; Nazrul Islam; Canice Ma; Aslam H Anis
Journal:  Pharmacoeconomics       Date:  2015-04       Impact factor: 4.981

3.  Emotion Regulation in Patients with Psoriasis: Correlates of Disability, Clinical Dimensions, and Psychopathology Symptoms.

Authors:  Vera Almeida; Sofia Taveira; Maribel Teixeira; Isabel Almeida; José Rocha; Ana Teixeira
Journal:  Int J Behav Med       Date:  2017-08

4.  Agreeableness and Self-Consciousness as Predictors of Induced Scratching and Itch in Patients with Psoriasis.

Authors:  C Schut; S Muhl; K Reinisch; A Claßen; R Jäger; U Gieler; J Kupfer
Journal:  Int J Behav Med       Date:  2015-12

5.  Reliability, validity and responsiveness to change of the Patient Report of Extent of Psoriasis Involvement (PREPI) for measuring body surface area affected by psoriasis.

Authors:  E D Dommasch; D B Shin; A B Troxel; D J Margolis; J M Gelfand
Journal:  Br J Dermatol       Date:  2009-11-10       Impact factor: 9.302

6.  Cost effectiveness of home ultraviolet B phototherapy for psoriasis: economic evaluation of a randomised controlled trial (PLUTO study).

Authors:  Mayke B G Koek; Vigfús Sigurdsson; Huib van Weelden; Paul H A Steegmans; Carla A F M Bruijnzeel-Koomen; Erik Buskens
Journal:  BMJ       Date:  2010-04-20

7.  The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathy.

Authors:  A M Huber; E M Dugan; P A Lachenbruch; B M Feldman; M D Perez; L S Zemel; C B Lindsley; R M Rennebohm; C A Wallace; M H Passo; A M Reed; S L Bowyer; S H Ballinger; F W Miller; L G Rider
Journal:  Rheumatology (Oxford)       Date:  2007-10       Impact factor: 7.580

8.  The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004.

Authors:  Shanu Kohli Kurd; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2008-11-20       Impact factor: 11.527

9.  Psychological Distress, Alexithymia and Alcohol Misuse in Patients with Psoriasis: A Cross-Sectional Study.

Authors:  Ourania Founta; Karoline Adamzik; Anne-Marie Tobin; Brian Kirby; David Hevey
Journal:  J Clin Psychol Med Settings       Date:  2019-06

10.  Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre randomised controlled non-inferiority trial (PLUTO study).

Authors:  Mayke B G Koek; Erik Buskens; Huib van Weelden; Paul H A Steegmans; Carla A F M Bruijnzeel-Koomen; Vigfús Sigurdsson
Journal:  BMJ       Date:  2009-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.